POTASSIUM PHOSPHATES (Potassium Phosphates in sodium chloride)
**Product type:** Human Prescription Drug
**Active ingredient:** POTASSIUM PHOSPHATE, DIBASIC; POTASSIUM PHOSPHATE, MONOBASIC
**Strength:** 4.72; 4.48 mg/mL; mg/mL
**Dosage form:** Injection
**Route:** Intravenous
**Labeler:** Amneal Pharmaceuticals LLC
**Marketing category:** NDA (NDA218343)
**Pharmacologic class:** Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC]
/api/v1/systems/ndc_fda/nodes/70121-1722Hierarchy Explorer
Cross-system equivalences0
No cross-system equivalences mapped for this node.